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Introduction
Immunoglobulin E (IgE) is best known for its association with allergic disease due to the activation of mast cells via the Fc-e receptor [1] . In addition, IgE has an important anti-toxic and anti-parasite effector function and may exert immunomodulatory effects [1, 2] . Depending on the assay used for quantification, the detection limit of serum IgE in clinical routine is between 2 and 4 kU/l. Normal IgE values of healthy individuals depend on age, but not gender [3] . The normal range of serum IgE in healthy individuals has changed in the last 20 years with a trend towards higher IgE levels [3, 4] . Many laboratories consider IgE levels > 100 kU/l as being elevated.
In primary immunodeficiencies (PID), the IgE antibody isotype is known mainly for its association with syndromes in which serum IgE levels are elevated significantly, the socalled 'hyper-IgE syndromes' . These syndromes consist of clinically and genetically distinct disease entities, including conditions with mutations in signal transducer and activator of transcription (STAT)-3 (Job's syndrome), dedicator of cytokinesis 8 (DOCK8) or phosphoglucomutase (PGM3) [5, 6] . High serum IgE levels may, however, also be found in a variety of other PID [7] . Surprisingly little is known about clinical entities that present with a low IgE result. Low serum IgE has been associated clinically with chronic fatigue and polyarthralgias [8] and a higher prevalence of autoimmune and oncological diseases and asthma, as well as chronic sinusitis and otitis media [9] . Recent studies found an association between low serum IgE levels and the levels of one or more classes of immunoglobulins (i.e. IgG, IgA and/or IgM) below the reference range for age [10, 11] . In line with these reports, a recent review concluded that low IgE levels should be considered as a clinical laboratory 'flag' to screen for antibody deficiency [12] . Some of these studies, however, may have been biased, as they correlated only immunoglobulin levels that had been measured for unspecified clinical reasons.
No study to date has analysed whether the patient group with low serum IgE (i) immunologically and (ii) clinically might represent a heterogeneous compilation of welldefined subgroups. The purpose of the present study was to close this gap by testing the association between low serum IgE levels (here defined as < 4 kU/l) and both (i) non-IgE immunoglobulin levels and (ii) clinical phenotypes. To achieve this, we performed a retrospective analysis of clinical and immunological parameters in patients from our outpatient immunodeficiency and out-patient allergy service, where serum IgE measurements are performed regularly.
Material and methods

Patients
Immunodeficiency referral patients consisted of patients from the adult out-patient immunodeficiency clinic at the University Hospital Basel, Switzerland, who presented for evaluation of an immunodeficiency between April 2012 and November 2014. Allergy referral patients who were included in the study consisted of gender-and agedmatched patients who presented between March 2011 and December 2013 at the allergy clinic of the same hospital. The patients were divided into three groups based on IgE levels: low IgE: IgE < 4 kU/l, normal IgE: IgE 10-100 kU/l and high IgE: IgE >100 kU/l. The study was approved by the local ethics committee.
Measurement of serum immunoglobulin levels
Total IgG, IgA, IgM, IgE and IgG subclass (IgG1, IgG2, IgG3 and IgG4) concentrations in serum were measured routinely by nephelometry using a BN ProSpec system (Siemens Healthcare Diagnostics, Z€ urich, Switzerland), according to the manufacturer's instructions. Results were generated using reagent and standard sets obtained from Siemens. Levels of IgG, IgA, IgM and IgG subclasses are expressed in g/l, while IgE levels are in kU/l. Samples with an IgE concentration below the lower limit of detection of the nephelometric IgE assay (i.e. 4 kU/l) were evaluated additionally by the ImmunoCAP total IgE low range fluorescence immunoassay (Thermo Fisher Scientific, Uppsala, Sweden) on a Phadia 250 instrument (Thermo Fisher) to obtain a precise determination. Both methods for IgE measurement are calibrated using standards traceable to the same 2nd World Health Organization International Reference Preparation of Human Serum Immunoglobulin E coded 75/502, and have been demonstrated recently to show excellent interassay agreement [13] .
Statistics
Significance tests were performed using the Kruskal-Wallis and Mann-Whitney U-tests. Differences between samples were regarded as significant if P < 0Á05. For correlations, Spearman's r and P-values were calculated. Data analysis was performed using the GraphPad Prism software (version 6.01) and the R statistical programming environment team (R Development Core. R: A Language and Environment for Statistical Computing, Vienna, Austria, 2015. http://www.R-project.org).
Hierarchical clustering
Heatmaps visualizing the hierarchical clustering of immunoglobulin profiles were established using the hclust-R function with default parameters and plotted using the heatmap function from the NMF R package [14] .
Results
Characterization of the study population
In our single-centre out-patient immunodeficiency clinic, IgE levels were measured prospectively in 88 patients (immunodeficiency referrals, patient characteristics Table 1,  clinical diagnosis Table 2 ). IgG, IgA, IgM and IgG subclasses were measured in all patients. None of the patients was on immunoglobulin substitution at the time of measurement.
Fifteen patients (17%) displayed an IgE concentration of < 4 kU/l, i.e. had a low-IgE result. In 51 (58%) immunodeficiency referral patients, serum IgE was normal (between 4 and 100 kU/l) and in 22 (25%) patients serum IgE was high (> 100 kU/l). From the 15 patients with a low IgE result, all except one (93%) were diagnosed as having primary or secondary antibody deficiency. Only one patient (7%) with a serum IgE level of < 4 kU/l had all immunoglobulin levels (including IgG subclasses) in a physiological range, and thus antibody deficiency was excluded (clinical diagnosis, Table 2 ). In the subset of immunodeficiency referral patients that presented with an IgE level > 4 kU/l, 47% received a clinical diagnosis of primary or secondary antibody deficiency, and in 53% an antibody deficiency was excluded. Using the hospital internal laboratory database we identified 28 patients evaluated in the out-patient allergy clinic (allergy referrals) presenting with serum IgE levels < 4 kU/l (low IgE result) that were age-and gender-matched to the immunodeficiency referral patients with a low IgE result (patient characteristics Table 1 , clinical diagnosis Table 3 ). As controls, we included 29 age-and gender-matched allergy referral patients with normal (IgE between 4 and 100 kU/l) and 32 patients with high serum IgE (IgE > 100 kU/l). IgG, IgM, IgA and IgG subclasses were measured in the sera of all these patients.
The correlation of IgE and IgG subclasses depends on the clinical phenotype
Using the data from the 177 patients (88 immunodeficiency referrals and 89 allergy referrals) we plotted correlations of IgE with IgG subclasses (Fig. 1 ). Significant positive correlations were found for IgG2, IgG3 and IgG4, while the correlation of IgG1 with IgE was not significant. The Spearman's r value was highest for IgG2 (0Á39) and IgG4 (0Á47) (Fig. 1) . We then plotted correlations of IgG subclasses with IgE separately for patients referred to the immunodeficiency clinic (blue) versus patients referred to the allergy clinic (red). Within the group of immunodeficiency referrals, IgE correlated significantly with all IgG subclasses, with the exception of IgG3 (Fig. 1) . The strongest positive correlations were found for IgG2 (Spearman's r 5 0Á6) and IgG4 (Spearman's r 5 0Á46). In contrast, within the group of allergy referrals, IgE correlated significantly with IgG2, IgG3 and IgG4, but not with IgG1 (Fig.  1) . The Spearman's r was highest for IgG3 (0Á36) and IgG4 (0Á40) in this patient group.
Thus, the correlation of IgE with IgG subclasses depended on the clinical phenotype, which dictated the clinic to which the patients were referred.
A low IgE result is associated with specific low IgG subclasses depending on the clinical phenotype Next we focused on patients who had an IgE level that was below detection limit (low IgE result). When immunodeficiency referral patients were grouped based on their serum IgE levels (low-IgE versus normal IgE versus high IgE), a low IgE result was associated significantly with low serum IgG and IgA, while serum IgM levels were not different (Fig. 2a) . While IgG1, IgG2 and IgG4 were all significantly lower in the low-IgE result group compared to the groups with normal and high IgE levels, respectively, IgG3 levels were not significantly different in immunodeficiency referral patients with a low IgE result (Fig. 2a) . In contrast to what was found in immunodeficiency referral patients, a low IgE result was not associated significantly with low total serum IgG and IgA in allergy referral patients (Fig. 2b) . IgM levels were similar to what was observed in immunodeficiency referrals (Fig. 2b) . In contrast to what was observed for immunodeficiency referrals with low serum IgE, a low IgE result in allergy referrals was associated with low IgG3 levels, while IgG1 and IgG2 subclass levels were normal (Fig. 2b) . Clinical chart review revealed that the main symptoms of allergy referral patients with a low IgE result were rhinitis/rhinoconjunctivitis and asthma (Table 3) .
Importantly, when the sera from patients with IgE > 4 kU/l from immunodeficiency referrals (excluding patients with the clinical diagnosis of antibody deficiency) were compared to allergy referrals, we did not find any statistical significance in IgG (including all IgG subclasses), IgA or IgM, indicating that the differences we observed within the two low-IgE groups were specific and not due to a systemic bias in immunoglobulin quantification (Supporting information, Fig. S1 ).
Hierarchical clustering substantiates the existence of two distinct patient groups with low IgE
To test further our hypothesis that patients with a low IgE result comprised two immunologically and clinically distinct groups, we performed unbiased hierarchical clustering of immunoglobulin profiles from patients with a low IgE result (including both immunodeficiency and allergy referrals). Immunodeficiency referrals with a low IgE result phenotype mainly clustered together, while the same was true for allergy referrals with a low IgE result (Fig. 3) . It is noteworthy that some patients (e.g. patient codes 36 and 38) evaluated in the allergy clinic showed immunoglobulin profiles matching closely the profile of patients with established diagnosis of antibody deficiency. In contrast, patient code 12 received the diagnosis of selective IgG3 deficiency, but displayed an immunoglobulin profile similar to allergy referral patients. Interestingly, selective IgG3 subclass deficiency has been shown to be associated with both recurrent respiratory tract infection and atopic disease [15, 16] .
Significantly lower serum IgE levels in immunodeficiency referral patients
The detection limit of 4 kU/l is not the technical limit of IgE quantification. When using a high sensitivity method that has a detection limit of 0Á35 kU/l (10-fold lower than the detection limit of the routine IgE quantification assay; see Methods) IgE levels were significantly lower in immunodeficiency referrals compared to allergy referral patients with a low IgE result (Fig. 4) . Thus, patients with a low IgE result (IgE < 4 kU/l) apparently consisted of patients with very low IgE (<0Á35 kU/l) and patients with IgE levels that are close to 4 kU/l.
(b) (a) Fig. 2 . Analysis of immunoglobulin (Ig) serum levels from immunodeficiency referrals (Fig. 2a) or allergy referrals (Fig. 2b ). Patients were classified based on IgE levels: low IgE 5 IgE < 4 kU/l, black circles normal IgE 5 4 kU/l < IgE < 100 kU/l, light grey circles and high IgE 5 IgE > 100 kU/l, dark grey circles. For statistical significance a Kruskal-Wallis test was performed. Significant differences are indicated: *P-value < 0Á05; **P < 0Á01; ***P < 0Á001; ****P < 0Á0001. 
Two types of low-IgE immune dysregulation
Discussion
Based on this retrospective single-centre study, the existence of two clinically and immunologically distinct low IgE cohorts can be postulated.
The first, defined here as low IgE type 1, is associated with antibody deficiency (low IgG and IgA) and susceptibility to infection and/or autoimmunity. If a secondary cause of antibody deficiency is unlikely, these patients are often diagnosed as common variable immunodeficiency (CVID). The only IgG subclass that was not altered significantly in low IgE type 1 was IgG3. Serum IgE levels from these patients were significantly lower than those from allergy referral patients when high sensitivity assays are used for quantification.
A low IgE type 2 pattern was characterized by specifically low levels of IgG3 and IgG4, but did not show reductions in other IgG subclasses. Total IgG and IgA levels were normal in patients with low IgE type 2. Serum IgE of these patients were mainly close to the commonly used cut-off of 4 kU/l. Low IgE type 2 patients were referred clinically to the out-patient allergy unit. Chart review revealed that the main symptoms were rhinitis and asthma.
Due to the limitations of a retrospective analysis we can only speculate about the type of immune dysregulation underlying a low IgE type 1 versus low IgE type 2 result. One possibility is that patients with a low IgE type 1 pattern have a similar but more advanced immune dysregulation compared to patients with a low IgE type 2 pattern. However, IgG3 being normal in low IgE type 1 but low in low IgE type 2 argues against this. IgG3 has distinct roles from other IgG subclasses. It has a much higher turnover than the other subclasses with a half-life of 7 versus 21 days, it is the best activator of complement and, together with IgE, is the first of the subclasses to appear in an immune response [17] . Thus, IgG3 joins the IgM-dependent early defence to bind and clear foreign antigens. It may thus not be surprising that IgG3 is the only subclass to remain normal in immunodeficient patients who usually suffer from chronic or repeated infections, while this plays a lesser role in allergy patients. Conversely, IgG2 as well as IgG1 are important for elicitation of anaphylaxis [18] and perhaps a lower-level, clinically undetectable state of allergen-dependent immune activation. This could explain why these subclasses show a contrast in low IgE type1 versus type 2.
As B cell subsets were available in immunodeficiency referral patients, we could show that low IgE type 1 was associated with low peripheral blood memory (CD27 shown). However, due to the retrospective type of analysis, no B cell subset data were available for low IgE type 2 patients.
The formation of IgE in vivo is only partially understood [19] . Although IgE is a class-switched Ig-isotype requiring CD40L expression by T helper cells [20] , total IgE levels are relatively high in mice or humans with T helper cell defects or complex human immunodeficiencies such as Wiskott Aldrich or Omenn syndrome [7, 21] . Class-switching to IgE can happen either directly or in a stepwise fashion via classswitching first to IgG1 and then to IgE [22] . Immature B cells switch preferentially from IgM directly to IgE by passing the intermediate class switch to IgG1 [22] . Direct or indirect class-switching to IgE has been shown to have an influence on whether a B cell differentiates into a memory B cell or an IgE-producing plasma cell [23] . Earlier studies have shown a correlation of IgE and IgA as mucosal immunoglobulins [24] . In our study, only low IgE type 1 was associated with low serum IgA, while IgA was mainly normal in IgE type 1 (Supporting information, Fig. S2 ).
Patients with antibody deficiencies are often diagnosed with a significant delay [12, 25] . This may be partly because the health-care professionals involved in evaluating these patients are unaware of this differential diagnosis. Some of these patients, due to shared symptoms such as rhinitis and coughing, will be evaluated in out-patient allergy units [25] . Our data imply that among patients evaluated in allergy clinics with low (< 4 kU/l) serum IgE, high sensitivity assays for serum IgE and/or analysis of IgG subclass levels could serve as a means to stratify these patients further. If IgG3 is normal, but other IgG subclasses (and IgA) are low and/or serum IgE is very low (< 0Á35 kU/l) and clinical evaluation does not reveal allergy as a probable cause of the patient symptoms, these individuals should be evaluated further for the diagnosis of antibody deficiency and might profit from immunoglobulin substitution.
Furthermore, patients with a low IgE type 2 pattern (low IgG3 and IgG4 but otherwise normal immunoglobulins) probably do not have classical antibody deficiency, but may represent a yet to be defined subcohort of patients with allergy-like symptoms.
The detailed clinical and immunological characterization of patients with a low IgE type 1 and low IgE type 2 pattern will be defined further in a prospective cohort study. Fig. 4 . High-sensitivity quantification of serum immunoglobulin (Ig)E levels in sera from the low-IgE patients (IgE < 4 kU/l); immunodeficiency referrals 5 closed symbols; allergy referrals 5 open symbols). Detection limit is 10-fold lower than with conventional assays used in clinics (cut-off < 0Á35 kU/l). For statistical significance a Mann-Whitney test was performed *(P-value < 0Á05). 
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